The path coefficient (β1) from baseline insulin to follow-up BMI did not differ significantly between MetS and non-MetS groups (p = 0.212) as well as between normoglycemic and hyperglycemic groups (p = 0.966). The gene discussed is INS; the disease is metabolic syndrome.